These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 19171382)
1. Side-on binding of p-sulphonatocalix[4]arene to the dinuclear platinum complex trans-[{PtCl(NH3)2}2mu-dpzm]2+ and its implications for anticancer drug delivery. Wheate NJ; Abbott GM; Tate RJ; Clements CJ; Edrada-Ebel R; Johnston BF J Inorg Biochem; 2009 Mar; 103(3):448-54. PubMed ID: 19171382 [TBL] [Abstract][Full Text] [Related]
2. Substituted beta-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators. Krause-Heuer AM; Wheate NJ; Tilby MJ; Pearson DG; Ottley CJ; Aldrich-Wright JR Inorg Chem; 2008 Aug; 47(15):6880-8. PubMed ID: 18597414 [TBL] [Abstract][Full Text] [Related]
3. A chemical preformulation study of a host-guest complex of cucurbit[7]uril and a multinuclear platinum agent for enhanced anticancer drug delivery. Kennedy AR; Florence AJ; McInnes FJ; Wheate NJ Dalton Trans; 2009 Oct; (37):7695-700. PubMed ID: 19759943 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, cytotoxicity, cell uptake and DNA interstrand cross-linking of 4,4'-dipyrazolylmethane-linked multinuclear platinum anti-cancer complexes. Wheate NJ; Cullinane C; Webster LK; Collins JG Anticancer Drug Des; 2001; 16(2-3):91-8. PubMed ID: 11962517 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, DNA binding and cytotoxicity of isohelical DNA groove binding platinum complexes. Wheate NJ; Webster LK; Brodie CR; Collins JG Anticancer Drug Des; 2000 Oct; 15(5):313-22. PubMed ID: 11354307 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines. Tayyem H; Huq F; Yu JQ; Beale P; Fisher K ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterisation, activities, cell uptake and DNA binding of a trinuclear complex: [[trans-PtCl(NH3)]2mu-[trans-Pd(NH3)(2-hydroxypyridine)-(H2)N(CH2)6NH2)2]Cl4. Cheng H; Huq F; Beale P; Fisher K Eur J Med Chem; 2006 Jul; 41(7):896-903. PubMed ID: 16730394 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterisation, activities, cell uptake and DNA binding of [[trans-PtCl(NH3)2] [mu-(H2N(CH2)6NH2)] [trans-PdCl(NH3)2](NO3)Cl. Huq F; Daghriri H; Yu JQ; Tayyem H; Beale P; Zhang M Eur J Med Chem; 2004 Nov; 39(11):947-58. PubMed ID: 15501544 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH(3))}(2)mu-{trans-Pt(NH(3))(2-hydroxypyridine)-(H(2)N(CH(2))(6)NH(2))(2)]Cl(4). Cheng H; Huq F; Beale P; Fisher K Eur J Med Chem; 2005 Aug; 40(8):772-81. PubMed ID: 16122580 [TBL] [Abstract][Full Text] [Related]
11. Application of fluorescence microscopy for investigation of cellular distribution of dinuclear platinum anticancer drugs. Kalayda GV; Zhang G; Abraham T; Tanke HJ; Reedijk J J Med Chem; 2005 Aug; 48(16):5191-202. PubMed ID: 16078838 [TBL] [Abstract][Full Text] [Related]
12. Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells. Boccarelli A; Giordano D; Natile G; Coluccia M Biochem Pharmacol; 2006 Jul; 72(3):280-92. PubMed ID: 16765322 [TBL] [Abstract][Full Text] [Related]
13. The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study. Deubel DV J Am Chem Soc; 2006 Feb; 128(5):1654-63. PubMed ID: 16448139 [TBL] [Abstract][Full Text] [Related]
14. In vitro biochemical and pharmacological evaluation of a novel cytotoxic dinuclear platinum(II) complex with 3-amino-5-methyl-5-phenylhydantoin. Momekov GTs; Ugrinova I; Pasheva EA; Bakalova AG; Varbanov HP; Ferdinandov DV; Ivanov DS; Konstantinov SM Ann N Y Acad Sci; 2009 Aug; 1171():649-58. PubMed ID: 19723116 [TBL] [Abstract][Full Text] [Related]
15. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes. Cubo L; Quiroga AG; Zhang J; Thomas DS; Carnero A; Navarro-Ranninger C; Berners-Price SJ Dalton Trans; 2009 May; (18):3457-66. PubMed ID: 19381408 [TBL] [Abstract][Full Text] [Related]
16. Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity. Griffith DM; Duff B; Suponitsky KY; Kavanagh K; Morgan MP; Egan D; Marmion CJ J Inorg Biochem; 2011 Jun; 105(6):793-9. PubMed ID: 21497577 [TBL] [Abstract][Full Text] [Related]
17. Synergism from combination of cisplatin and a trans-platinum compound in ovarian cancer cell lines. Alshehri A; Beale P; Yu JQ; Huq F Anticancer Res; 2010 Nov; 30(11):4547-53. PubMed ID: 21115904 [TBL] [Abstract][Full Text] [Related]
18. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base. Roy S; Westmaas JA; Buda F; Reedijk J J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572 [TBL] [Abstract][Full Text] [Related]
19. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)]. Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194 [TBL] [Abstract][Full Text] [Related]